Free Trial

NFJ Investment Group LLC Decreases Stock Position in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

NFJ Investment Group LLC lessened its stake in shares of Genpact Limited (NYSE:G - Free Report) by 17.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 498,430 shares of the business services provider's stock after selling 105,131 shares during the quarter. NFJ Investment Group LLC owned about 0.28% of Genpact worth $21,408,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of G. SRH Advisors LLC purchased a new position in Genpact in the fourth quarter worth $26,000. Atlas Capital Advisors Inc. boosted its stake in Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after acquiring an additional 216 shares during the last quarter. Manchester Capital Management LLC bought a new position in shares of Genpact during the 4th quarter valued at approximately $38,000. Smartleaf Asset Management LLC increased its stake in shares of Genpact by 416.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock worth $41,000 after purchasing an additional 783 shares during the last quarter. Finally, UMB Bank n.a. raised its holdings in shares of Genpact by 55.7% in the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after purchasing an additional 433 shares during the period. 96.03% of the stock is currently owned by institutional investors.

Genpact Stock Down 1.7 %

Shares of NYSE:G traded down $0.81 during trading on Monday, hitting $46.79. The stock had a trading volume of 98,333 shares, compared to its average volume of 1,477,996. The company has a market capitalization of $8.22 billion, a PE ratio of 16.48, a PEG ratio of 1.84 and a beta of 1.06. The firm's fifty day moving average is $50.52 and its 200 day moving average is $46.13. Genpact Limited has a 12 month low of $30.38 and a 12 month high of $56.76. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50.

Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. Analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were issued a dividend of $0.17 per share. This is an increase from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date was Tuesday, March 11th. Genpact's dividend payout ratio is presently 23.94%.

Insider Buying and Selling at Genpact

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 2.80% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and boosted their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Mizuho raised their price target on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Needham & Company LLC upped their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Finally, Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Six equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $48.44.

Get Our Latest Stock Report on G

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines